← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2010Last known activity
Aug 6, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT07019415Sponsor investigatorN/AAug 6, 2024
- NCT07019415Lead sponsorN/AAug 6, 2024
- NCT05596383Lead sponsorN/AFeb 12, 2022
- NCT05596383Reponsible party - principal investigatorN/AFeb 12, 2022
- NCT05596383Sponsor investigatorN/AFeb 12, 2022
- NCT04847960Lead sponsorN/AMar 22, 2021
- NCT04847960Reponsible party - principal investigatorN/AMar 22, 2021
- NCT04847960Overall official - principal investigatorN/AMar 22, 2021
- NCT04847960Study chairN/AMar 22, 2021
- NCT01463436Lead sponsorPhase 3Jan 1, 2010
- NCT01463436Reponsible party - principal investigatorPhase 3Jan 1, 2010
- NCT01463436Overall official - principal investigatorPhase 3Jan 1, 2010
Details
- Last known activity
- Aug 6, 2024